Abstract:The ubiquitin-proteasome system (UPS) promotes the timely degradation of short-lived proteins with key regulatory roles in a vast array of biological processes, such as cell cycle progression, oncogenesis and genome integrity. Thus, abnormal regulation of UPS disrupts the protein homeostasis and causes many human diseases, particularly cancer. Indeed, the FDA approval of bortezomib, the first class of general proteasome inhibitor, for the treatment of multiple myeloma, demonstrated that the UPS can be an attractive anti-cancer target. However, normal cell toxicity associated with bortezomib, resulting from global inhibition of protein degradation, promotes the focus of drug discovery efforts on targeting enzymes upstream of the proteasome for better specificity. E3 ubiquitin ligases, particularly those known to be activated in human cancer, become an attractive choice. Cullin-RING Ligases (CRLs) with multiple components are the largest family of E3 ubiquitin ligases and are responsible for ubiquitination of similar to 20% of cellular proteins degraded through UPS. Activity of CRLs is dynamically regulated and requires the RING component and cullin neddylation. In this review, we will introduce the UPS and CRL E3s and discuss the biological processes regulated by each of eight CRLs through substrate degradation. We will further discuss how cullin neddylation controls CRL activity, and how CRLs are being validated as the attractive cancer targets by abrogating the RING component through genetic means and by inhibiting cullin neddylation via MLN4924, a small molecule indirect inhibitor of CRLs, currently in several Phase I clinical trials. Finally, we will discuss current efforts and future perspectives on the development of additional inhibitors of CRLs by targeting E2 and/or E3 of cullin neddylation and CRL-mediated ubiquitination as potential anti-cancer agents.

Cullin 4-DCAF Proteins in Tumorigenesis

The Functions and Properties of Cullin-5, a Potential Therapeutic Target for Cancers.

Cullin-RING Ligase 4 in Cancer: Structure, Functions, and Mechanisms

The emerging role for Cullin 4 family of E3 ligases in tumorigenesis

Cullin-RING ligases in regulation of autophagy

Cullin Family Proteins and Tumorigenesis: Genetic Association and Molecular Mechanisms

Pathogenic Roles of the Cullin E3 Ligase Scaffolding Protein CUL4B

Cullin-Ring Ligase 5: Functional Characterization And Its Role In Human Cancers

Cullin-RING Ligase 5: Functional Characterization and Its Role in Human Cancers.

CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.

The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer

Functional analysis of Cullin 3 E3 ligases in tumorigenesis

Cullin1 and malignant tumors

Progress in the Mechanism of CUL4A and Its Relationship with Tumors

Recent Insight into the Role of RING-finger E3 Ligases in Glioma

Cullin-RING Ligases as attractive anti-cancer targets.

Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.

CRL3s: The BTB-CUL3-RING E3 Ubiquitin Ligases

Cullin-RING E3 ubiquitin ligase 4 regulates neurite morphogenesis during neurodevelopment

CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing

Phosphorylation regulates cullin-based ubiquitination in tumorigenesis